Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroprotection in multiple sclerosis.

Dimitrios Karussis1, Savas Grigoriadis, Eleni Polyzoidou

  • 1Department of Neurology and the Agnes Ginges Center for Neurogenetics, Laboratory of Neuroimmunology, Hadassah University Hospital, Jerusalem, Ein-Karem IL-91120, Israel. karus@cc.huji.ac.il

Clinical Neurology and Neurosurgery
|January 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.

Brain sciences·2026
Same author

A neurologist's guide to VEXAS syndrome: Differentiating somatic autoinflammation from autoimmune mimics.

Intractable & rare diseases research·2026
Same author

Exploring the Personalisation of Digital Cognitive Rehabilitation in Multiple Sclerosis Through Wearable Data and Machine Learning.

Studies in health technology and informatics·2026
Same author

Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.

Frontiers in public health·2026
Same author

Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.

Clinical neurology and neurosurgery·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026

Bone marrow stem cells show promise for multiple sclerosis (MS) treatment by differentiating into neuronal cells and suppressing disease symptoms. Combining stem cell therapy with immunomodulation may offer maximal clinical benefit for MS patients.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Immunology

Background:

  • Multiple sclerosis (MS) involves irreversible neuronal and glial cell damage, leading to brain atrophy and disability.
  • Neuroprotection strategies aim to prevent cell damage and promote regeneration in chronic inflammatory diseases like MS.
  • Bone marrow-derived stem cells are a promising avenue for neuroprotection and potential regeneration in MS.

Purpose of the Study:

  • To investigate the neuroprotective and immunomodulatory potential of bone marrow-derived stem cells in a model of chronic multiple sclerosis.
  • To assess the ability of bone marrow stromal cells to differentiate into neuronal and glial lineages.
  • To evaluate the therapeutic efficacy of stem cell transplantation in suppressing clinical signs of experimental autoimmune encephalomyelitis (EAE).

Related Experiment Videos

Main Methods:

  • Administration of bone marrow-derived stromal cells via intravenous or intracerebral/intraventricular injection in a chronic EAE model.
  • Assessment of stem cell differentiation into neuronal and glial cells in vivo.
  • Monitoring of clinical signs and disease progression in EAE models following stem cell treatment.

Main Results:

  • Bone marrow-derived stromal cells demonstrated differentiation into neuronal and glial cells.
  • Stem cell treatment significantly suppressed the clinical signs of chronic experimental autoimmune encephalomyelitis (EAE).
  • Preliminary findings suggest a therapeutic potential for bone marrow and neuronal stem cells in MS.

Conclusions:

  • Bone marrow-derived stem cells possess neuroprotective and immunomodulatory properties relevant to multiple sclerosis.
  • Stem cell therapy, potentially combined with immunomodulation, represents a promising therapeutic strategy for MS.
  • Further research into stem cell applications could lead to enhanced neuroprotection and regeneration in MS treatment.